Instructions de recherche:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Parcourir les contenus (107 total)
-
Créateur: Arabi, Yaseen M., Ayed Y. Asiri, Abdullah M. Assiri, Hanan H. Balkhy, Ali Al Bshabshe, Majed Al Jeraisy, Yasser Mandourah, Mohamed H. A. Azzam, Abdulhadi M. Bin Eshaq, Sameera Al Johani, Shmeylan Al Harbi, Hani A. A. Jokhdar, Ahmad M. Deeb, Ziad A.…
Sujet: Laboratory
Type d'élément: Publication
Date de la dernière mise à jour: 2020-10-07
Description: Whether combined treatment with recombinant interferon beta-1b and lopinavir–ritonavir reduces mortality among patients hospitalized with Middle East respiratory syndrome (MERS) is unclear. -
Créateur: Isakov, A., A. Jamison, W. Miles and B. Ribner
Sujet: Pre-Hospital
Type d'élément: Publication
Date de la dernière mise à jour: 2014-12-02
Description: Health care workers (HCWs) in the emergency medical services (EMS) and hospital settings often encounter patients infected with dangerous communicable diseases. -
Créateur: Florescu, D. F., A. C. Kalil, A. L. Hewlett, A. J. Schuh, U. Stroher, T. M. Uyeki and P. W. Smith
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2015-09-15
Description: From 2014 to May 2015, >26 000 Ebola virus disease (EVD) cases were reported from West Africa. -
Créateur: Kraft, C. S.
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2016-11-15
Description: Since the discovery of Ebola virus in the Democratic Republic of Congo in 1976, outbreaks of EVD had been mainly confined to rural areas (http://www.cdc.gov/vhf/ebola/outbreaks/history/chronology.html)... -
Créateur: Kraft, C. S., A. L. Hewlett, S. Koepsell, A. M. Winkler, C. J. Kratochvil, L. Larson, J. B. Varkey, A. K. Mehta, G. M. Lyon, 3rd, R. J. Friedman-Moraco, V. C. Marconi, C. E. Hill, J. N. Sullivan, D. W. Johnson, S. J. Lisco, M. J. Mulligan, T. M.…
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2015-08-15
Description: The current West Africa Ebola virus disease (EVD) outbreak has resulted in multiple individuals being medically evacuated to other countries for clinical management. -
Créateur: McElroy, A. K., R. S. Akondy, J. R. Harmon, A. H. Ellebedy, D. Cannon, J. D. Klena, J. Sidney, A. Sette, A. K. Mehta, C. S. Kraft, M. G. Lyon, J. B. Varkey, B. S. Ribner, S. T. Nichol and C. F. Spiropoulou
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2017-06-15
Description: A nurse who acquired Lassa virus infection in Togo in the spring of 2016 was repatriated to the United States for care at Emory University Hospital. -
Créateur: McElroy, A. K., J. R. Harmon, T. D. Flietstra, S. Campbell, A. K. Mehta, C. S. Kraft, M. G. Lyon, J. B. Varkey, B. S. Ribner, C. J. Kratochvil, P. C. Iwen, P. W. Smith, R. Ahmed, S. T. Nichol and C. F. Spiropoulou
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2016-08-15
Description: Ebola virus (EBOV) infection causes a severe and often fatal disease.An updated was made in Erratum on 2017 July 5. -
Créateur: National Academies of Sciences, E. and Medicine
Sujet: Research
Type d'élément: Publication
Date de la dernière mise à jour: 2017-10-31
Description: During public health emergencies (PHEs) involving chemical, biological, radiological, or nuclear threats or emerging infectious diseases, medical countermeasures (MCMs) (e.g., drugs, vaccines, devices) may need to be dispensed or administered to… -
Créateur: American Society for Microbiology
Sujet: Research
Type d'élément: Vidéo
Date de la dernière mise à jour: 2018-01-02
Description: This video explores the National Emerging Infectious Diseases Laboratories (NEIDL) security, a Biological Safety Level (BSL)-4 safety suit, and the facility. -
Créateur: U.S. Food and Drug Administration (FDA)
Sujet: Research
Type d'élément: Guide
Date de la dernière mise à jour: 2018-08-13
Description: FDA CDER statisticians are designing trials with adaptive features to make clinical evaluation of new drug treatments more efficient and informative. (FDA)More information on the subject can be read here.